Pierre Fabre Laboratories and Vernalis (R&D) Ltd, a fully owned subsidiary of HitGen Inc., entered into a long-term partnership to identify preclinical candidates against multiple oncology targets. Under the terms of the agreement, Vernalis will use its expertise to enable drug discovery against an undisclosed portfolio of targets and use fragment and structure-based methods to identify small molecules that modulate their activity. This research will be combined with the oncology experien...